BioCentury
ARTICLE | Financial News

JHL raises financing at $750M valuation

October 5, 2018 6:22 PM UTC

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised an undisclosed amount in a private financing at a valuation of $750 million. Participating in the financing were Sanofi (Euronext:SAN; NYSE:SNY) and other undisclosed investors, according to a source familiar with the deal who asked not to be named.

In May, JHL raised $106 million in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Ruihua Investment and Milestone Capital also participated (see "JHL Raises $106M in Bond Deal")...

BCIQ Company Profiles

Eden Biologics Inc.

Sanofi